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Hospital Acquired Pneumonia incidence and diagnosis in older patients 
 
ABSTRACT 
 
Background 
Hospital-acquired pneumonia poses a hazard to older people who are hospitalized, yet few data 
exist on the incidence or risk factors in non-intensive care patients. This study aimed to 
determine the incidence of, and risk markers for, Hospital Acquired Pneumonia (HAP) in a 
sample of hospitalized older people.  
 
Methods 
Prospective survey of hospitalized older patients (>65 years) at a single centre over a 12 month 
period. Casenote and chart data were collected on acute medical, orthopaedic and Medicine for 
the Elderly wards. Hospital-acquired pneumonia was defined in accordance with the European 
and Scottish National Prevalence Survey 2011 definition. Key analyses were incidence of 
clinically suspected and case-definition clinically confirmed HAP. 
 
Results 
1302 patients were included in the analysis. 539 (41%) were male, mean age was 82 years (SD 
8). Median length of hospital stay was 14 days (IQR 20). 157 episodes of HAP were clinically 
suspected in 143 patients (10.9% of admissions), but only 83 episodes in 76 patients met the 
diagnostic criteria (5.8% of admissions). The risk of HAP was 0.3% per day in hospital. 
Reasons for failure to meet the diagnostic criteria in 75 cases were lack of radiographic 
evidence in 60/75; lack of evidence of inflammation in 42/75, and lack of respiratory signs or 
symptoms in 13/75; 35/75 (47%) of cases lacked evidence in 2 or more domains.  
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Conclusion 
HAP is common but over-diagnosed in older hospitalised patients. 
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Introduction 
The incidence of hospital-acquired pneumonia (HAP) is not well studied outside the Intensive 
Care Unit, but estimates range from less than 1% of all hospital admissions[1-4] to between 
8% and 10% of patients admitted to medicine for the elderly units[5-8]. Older people spend 
longer in hospital, have relative immune compromise, and are commonly exposed to multiple 
courses of antibiotics. They are more likely to have swallowing dysfunction leading to 
aspiration of oropharyngeal material, which in older hospitalized patients includes pathogenic 
bacteria in 45% of cases; such bacteria are associated with an increased risk of HAP[9,10] 
 
Studies of HAP to date have focused mainly on ventilator-associated pneumonia in Intensive 
Care Units; patient characteristics, risk factors and preventative approaches may be very 
different in older, ward-based patients[11-13]. Few studies have attempted to estimate the 
incidence of, or risk factors for HAP among the general population of older hospitalised 
patients. In addition, clinical experience suggests that a diagnosis of HAP is often made without 
reference to standardised diagnostic criteria, potentially overestimating the incidence. We 
therefore conducted a prospective survey to determine the incidence of HAP and to determine 
how often clinically diagnosed HAP meets standardized diagnostic criteria in older hospitalized 
patients.  
 
Methods 
Study design, setting and population 
We surveyed older people admitted to Ninewells Hospital and Royal Victoria Hospital, NHS 
Tayside, Dundee, from 1st August 2012 to 31st July 2013. We capped the number of consecutive 
admissions sampled during each quarter (400 for first quarter, 300 for subsequent quarters) to 
allow follow up from medical notes to be completed. We studied the first admission for each 
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patient during the study period; subsequent admissions were not included, but readmissions for 
pneumonia within 28 days of discharge were counted as episodes of suspected or clinically 
confirmed HAP. We selected four Acute Medical and Medicine for the Elderly wards at 
Ninewells Hospital, four subacute Medicine for the Elderly wards at Royal Victoria Hospital, 
Dundee and three Orthopaedic wards at Ninewells Hospital, Dundee. The admission window 
for each patient was taken as the date of admission to any acute hospital ward to the date of 
discharge from either the acute or subacute hospital (thus discharge to home, care home, 
intermediate care or community hospital was taken as the date of discharge). 
 
To avoid selection bias resulting from the requirement to obtain consent, we did not approach 
patients directly as part of this survey; instead we used routinely collected data from medical 
notes, nursing notes and prescribing charts. We gained approval from the local Caldicott 
Guardian (data protection officer) prior to commencing data collection. All patients aged >65 
years admitted to the targeted hospital wards were included in the survey. Ethics committee 
approval was not required as the only data used were routinely collected healthcare data 
without additional patient contact. 
 
Data collection 
Data on baseline demographics, medication use at admission, comorbid disease recorded in the 
hospital and primary care medical notes, pre-hospital antibiotic use noted on the GP admission 
letter (in the 14 days prior to hospital admission) and all episodes of in-hospital antibiotic use 
for prophylaxis or treatment were collected. We recorded swallowing problems (noted by the 
patient or by nursing staff without formal testing) and the presence or absence of dentures from 
hospital nursing notes. We ascertained new episodes of infection by scrutinizing the 
prescription charts of all admitted patients for new antibiotic prescriptions. These patients then 
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underwent notes review by medically qualified researchers to ascertain the clinical indication 
for prescription, and to ascertain whether the case definition for clinically confirmed hospital-
acquired pneumonia was met. 
 
The case definition of clinically confirmed hospital-acquired pneumonia[14] was: onset >48 
hrs after admission, plus a) two or more serial chest radiograph or computed tomography (CT) 
scans with a suggestive image of pneumonia for patients with underlying cardiac/pulmonary 
disease (or one definitive chest radiograph or CT scan if no underlying disease) as noted by 
either the attending clinician or reporting radiologist; and b) a fever >38oC with no other cause 
or white cell count <4x109/L or >12x109/L; and c) at least one of:  new onset purulent sputum 
or change in character of sputum, cough/dyspnoea/tachypnoea, suggestive auscultation 
(crepitations or bronchial breath sounds), rhonchi or wheezing, worsening gas exchange. 
Suspected but not clinically confirmed episodes were defined as episodes where the clinical 
team had at any point recorded a diagnosis of ‘pneumonia’ or ‘respiratory tract infection’ or 
‘chest infection’ and started antibiotic therapy, but which did not fulfil the case definition 
above.  
 
Data Analysis 
All data analyses were performed using SPSS v21 (IBM, New York, USA). We calculated the 
percentage of patients with suspected HAP, the percentage of those with clinically confirmed 
HAP and the cumulative risk of HAP by duration of admission as well as the risk of HAP event 
per day of hospital admission. We determined the case fatality rate (i.e. the percentage of those 
who died prior to hospital discharge) in those with suspected and clinically confirmed HAP 
episodes. We generated descriptive statistics for the reasons leading to failure to confirm the 
diagnosis of HAP in suspected, but not clinically confirmed cases. 
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Results 
We studied a total of 1307 patients, of whom 1302 had complete data and are included in this 
analysis. Baseline characteristics are given in Supplementary Table 1 (appendix 1). Medical 
records were not available for scrutiny for the five patients excluded from analysis. 
 
The number of HAP episodes per patient group is shown in Table 1. There were a total of 157 
episodes of suspected HAP in 143 patients (10.9% of all studied admissions) but only 83 
episodes in 76 patients met the diagnostic criteria (5.8% of all studied admissions). The overall 
risk of clinically confirmed HAP per day of admission was 0.3% and remained constant 
through to at least 80 days after admission. The in-hospital death rate was 22/76 (29%) in 
patients with clinically confirmed HAP, 13/67 (19%) in patients with suspected but not 
clinically confirmed HAP cases and 97/1159 (8%) in patients with no episodes of suspected 
HAP. Of the patients with clinically confirmed HAP, 72 (87%) had a single episode. Only 9 
(6.3%) of patients with suspected HAP and 4 (5.3%) of patients with clinically confirmed HAP 
had multiple episodes of HAP. 
 
For the 75 suspected cases not meeting the diagnostic criteria for HAP, the reasons for failing 
to meet the criteria were lack of radiographic evidence, lack of inflammatory evidence, or lack 
of respiratory evidence (Figure 1). No significant differences in reasons were noted between 
different ward types. 
 
Discussion 
Our estimate of HAP incidence is at the upper end of previous estimates[5,15]. Some previous 
studies with high reported incidence included intensive care settings, which our study did not. 
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Previous studies found that HAP incidence rates were higher in patients in intermediate (8.3%) 
and long term care (5.3%) compared to short term care (0.5%) [5]. The high mortality that we 
found in clinically confirmed cases of HAP is both expected and consistent with other 
studies[2,15]. 
 
Previous studies have shown that in non-ICU settings HAP was more common in postoperative 
patients[10,16], contrary to our findings. This may be due in part to the longer length of stay 
and greater co-morbidities of the patients admitted to Medicine for the Elderly wards compared 
to those on orthopaedic wards, many of whom were elective patients undergoing surgery with 
spinal anaesthesia. Of note, older patients with lower limb fracture (a frailer group with 
multiple comorbidity) had a HAP rate of 10% in a recent study[10]. 
 
Almost half of suspected HAP cases did not fulfil the diagnostic criteria used in this survey. 
The criteria may be overly rigorous, and hence miss atypical presentations of genuine 
pneumonia in this population. However, in approximately half of cases not reaching the 
criteria, two or three domains of evidence were lacking, making a diagnosis of HAP unlikely. 
Potentially large numbers of patients may thus receive inappropriate antibiotic therapy or have 
an alternative, treatable diagnosis overlooked. Even in those patients where antibiotic therapy 
might still have been appropriate, an alternative diagnosis may have altered the choice, duration 
or dose of antibiotic therapy. 
 
Using routinely collected ward data allowed us to include patients with delirium and dementia, 
enhancing the generalizability of our findings. We used pre-defined criteria for identifying 
HAP which allowed more accurate diagnosis than relying on hospital episode statistics. The 
criteria used have not been validated specifically for older people so some genuine cases of 
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HAP may have been coded as suspected but not confirmed; for instance some changes may 
have been missed by plain chest radiography, but might have been detectable on CT. 
Microbiological data were not available for the vast majority of patients, and we were unable 
to collect a formal measure of frailty. Patients were not followed up after discharge; hence the 
HAP rate and mortality following HAP may be underestimated. Similarly, a lack of data on 
pneumonia rates amongst this cohort in the community makes it impossible to calculate the 
excess risk of pneumonia attributable to hospitalization, rather than to the presence of other 
risk factors. 
 
Our findings suggest that further work is needed: incidence studies in other populations, 
exploration of the reasons for misdiagnosis, refinement of diagnostic criteria for use in older 
patients, development of risk scores to identify low or high risk subgroups of patients, and 
finally development and evaluation in trials of multicomponent interventions to prevent this 
common and dangerous condition, 
 
Acknowledgements: None.  
Conflict of interest: None to declare 
Funding: From NHS Tayside endowment grant funds 
 
  
10  
References 
 
1. Masterton RG, Galloway A, French G, et al. Guidelines for the management of hospital-
acquired pneumonia in the UK: report of the working party on hospital-acquired pneumonia of 
the British Society for Antimicrobial Chemotherapy. J Antimicrob Chemother 2008; 62: 5-34. 
2. Sopena N, Sabria M. Multicenter study of hospital-acquired pneumonia in non-ICU patients. 
Chest 2005; 127: 213-9. 
3. Fortaleza CM, Abati PA, Batista MR, Dias A. Risk factors for hospital-acquired pneumonia 
in nonventilated adults. Braz J Infect Dis 2009; 13: 284-8. 
4. Giannella M, Pinilla B, Capdevila JA, et al. Pneumonia treated in the internal medicine 
department: focus on healthcare-associated pneumonia. Clin Microbiol Infect 2012; 18: 786-
94. 
5. Rothan-Tondeur M, Meaume S, Girard L, et al. Risk factors for nosocomial pneumonia in a 
geriatric hospital: a control-case one-center study. J Am Geriatr Soc 2003; 51: 997-1001. 
6. Stolbrink M, McGowan L, Saman H, et al. The Early Mobility Bundle: a simple 
enhancement of therapy which may reduce incidence of hospital-acquired pneumonia and 
length of hospital stay. J Hosp Infect 2014; 88: 34-9. 
7. Leu HS, Kaiser DL, Mori M, Woolson RF, Wenzel RP. Hospital-acquired pneumonia. 
Attributable mortality and morbidity. Am J Epidemiol 1989; 129: 1258-67. 
8. Harkness GA, Bentley DW, Roghmann KJ. Risk factors for nosocomial pneumonia in the 
elderly. Am J Med 1990; 89: 457-63. 
9. Ewan V, Perry JD, Mawson T, et al. Detecting potential respiratory pathogens in the mouths 
of older people in hospital. Age Ageing 2010; 39: 122-5. 
11  
10. Ewan VC, Sails AD, Walls AW, Rushton S, Newton JL.  Dental and microbiological risk 
factors for hospital-acquired pneumonia in non-ventilated older patients. PLoS One 2015; 10:  
e0123622. 
11. Rello J, Lorente C, Diaz E, et al. Incidence, etiology, and outcome of nosocomial 
pneumonia in ICU patients requiring percutaneous tracheotomy for mechanical ventilation. 
Chest 2003; 124: 2239-43. 
12. Hospital-acquired pneumonia in adults: diagnosis, assessment of severity, initial 
antimicrobial therapy, and preventive strategies. A consensus statement, American Thoracic 
Society, November 1995. Am J Respir Crit Care Med 1996; 153: 1711-25. 
13. McAuley SM, Price RJG, Phillips G, Marwick CA, McMurdo MET, Witham MD. 
Interventions to prevent non-critical care hospital acquired pneumonia – a systematic review. 
Eur Geriatr Med 2015; 6: 336-40. 
14. Health Protection Scotland. European and Scottish National Prevalence Survey of 
Healthcare Associated Infection and Antimicrobial Prescribing Data Collection Protocol.  
2011. 
15. Avci M, Ozgenc O, Coskuner SA, Olut AI. Hospital acquired infections (HAI) in the 
elderly: comparison with the younger patients. Arch Gerontol Geriatr 2012; 54: 247-50. 
16. Craven DE, Steger KA. Epidemiology of nosocomial pneumonia. New perspectives on an 
old disease. Chest 1995; 108(2 suppl): 1S-16S. 
  
12  
 
 
 
Table 1. Incidence of hospital-acquired pneumonia (HAP) 
Parameter Acute 
(n=729) 
Subacute 
(n=235) 
Orthopaedic 
(n=338) 
All 
(n=1302) 
No. of patients with suspected HAP (%) 77 (10.6) 35 (14.9) 31 (9.2) 143 (10.9) 
Suspected HAP episodes 84 42 31 157 
No. of patients with clinically confirmed 
HAP (%) 
43 (5.9) 23 (9.8) 10 (3.0) 76 (5.8) 
Clinically confirmed HAP episodes 47 26 10 83 
% suspected cases confirmed clinically 56% 62% 32% 53% 
Total days spent in hospital 14753 8177 4833 27763 
Risk of HAP per day in hospital 0.32% 0.32% 0.21% 0.30% 
  
HAP: Hospital-acquired pneumonia 
  
13  
 
Fig 1. Reasons for failure to meet diagnostic criteria in patients with suspected, but 
unconfirmed Hospital-Acquired pneumonia (n=75) 
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